211 related articles for article (PubMed ID: 23853559)
1. Middle-of-the-night hypnotic use in a large national health plan.
Roth T; Berglund P; Shahly V; Shillington AC; Stephenson JJ; Kessler RC
J Clin Sleep Med; 2013 Jul; 9(7):661-8. PubMed ID: 23853559
[TBL] [Abstract][Full Text] [Related]
2. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
Roth T; Hull SG; Lankford DA; Rosenberg R; Scharf MB;
Sleep; 2008 Sep; 31(9):1277-84. PubMed ID: 18788653
[TBL] [Abstract][Full Text] [Related]
3. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
[TBL] [Abstract][Full Text] [Related]
4. Effects of different doses of triazolam in the middle-of-the-night insomnia: a double-blind, randomized, parallel group study.
Ferini Strambi L; Marelli S; Zucconi M; Galbiati A; Biggio G
J Neurol; 2017 Jul; 264(7):1362-1369. PubMed ID: 28584913
[TBL] [Abstract][Full Text] [Related]
5. Impact of middle-of-the-night awakenings on health status, activity impairment, and costs.
Moline M; DiBonaventura Md; Shah D; Ben-Joseph R
Nat Sci Sleep; 2014; 6():101-11. PubMed ID: 25093001
[TBL] [Abstract][Full Text] [Related]
6. On-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics.
Leufkens TR; Ramaekers JG; de Weerd AW; Riedel WJ; Vermeeren A
Psychopharmacology (Berl); 2014 Jul; 231(14):2851-65. PubMed ID: 24488406
[TBL] [Abstract][Full Text] [Related]
7. Nighttime versus daytime hypnotic self-administration.
Roehrs T; Bonahoom A; Pedrosi B; Zorick F; Roth T
Psychopharmacology (Berl); 2002 May; 161(2):137-42. PubMed ID: 11981593
[TBL] [Abstract][Full Text] [Related]
8. Individualizing therapy for early, middle-of-the-night and late-night insomnia.
Scharf MB
Int J Clin Pract Suppl; 2001 Jan; (116):20-4. PubMed ID: 11219329
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of as-needed, post bedtime dosing with indiplon in insomnia patients with chronic difficulty maintaining sleep.
Roth T; Zammit GK; Scharf MB; Farber R
Sleep; 2007 Dec; 30(12):1731-8. PubMed ID: 18246982
[TBL] [Abstract][Full Text] [Related]
10. Patterns of sleep-related medications prescribed to elderly outpatients with insomnia in Taiwan.
Huang WF; Lai IC
Drugs Aging; 2005; 22(11):957-65. PubMed ID: 16323972
[TBL] [Abstract][Full Text] [Related]
11. Sleep pattern and predictors of daily versus as-needed hypnotics use in middle-aged and older adults with insomnia.
Tanielian M; Antoun J; Sidani M; Halabi A; Hoballah M; Hawatian K; Assaf G
BMC Prim Care; 2022 May; 23(1):98. PubMed ID: 35501700
[TBL] [Abstract][Full Text] [Related]
12. Patterns of hypnotic prescribing for residual insomnia and recurrence of major depressive disorder: a retrospective cohort study using a Japanese health insurance claims database.
Yamato K; Inada K; Enomoto M; Marumoto T; Takeshima M; Mishima K
BMC Psychiatry; 2021 Jan; 21(1):40. PubMed ID: 33441086
[TBL] [Abstract][Full Text] [Related]
13. Treatment of insomnia with zaleplon, a novel sleep medication.
Doghramji PP
Int J Clin Pract; 2001 Jun; 55(5):329-34. PubMed ID: 11452683
[TBL] [Abstract][Full Text] [Related]
14. Zaleplon: a review of its use in the treatment of insomnia.
Dooley M; Plosker GL
Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
[TBL] [Abstract][Full Text] [Related]
15. Beliefs about prescription sleep medications and interest in reducing hypnotic use: an examination of middle-aged and older adults with insomnia disorder.
Tully IA; Kim JP; Simpson N; Palaniappan L; Tutek J; Gumport NB; Dietch JR; Manber R
J Clin Sleep Med; 2023 Jul; 19(7):1247-1257. PubMed ID: 36883379
[TBL] [Abstract][Full Text] [Related]
16. An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients.
Frighetto L; Marra C; Bandali S; Wilbur K; Naumann T; Jewesson P
Health Qual Life Outcomes; 2004 Mar; 2():17. PubMed ID: 15040803
[TBL] [Abstract][Full Text] [Related]
17. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.
Morgan K; Dixon S; Mathers N; Thompson J; Tomeny M
Health Technol Assess; 2004 Feb; 8(8):iii-iv, 1-68. PubMed ID: 14960254
[TBL] [Abstract][Full Text] [Related]
18. The need for flexibility in dosing of hypnotic agents.
Doghramji K
Sleep; 2000 Feb; 23 Suppl 1():S16-20; discussion S21-2. PubMed ID: 10755804
[TBL] [Abstract][Full Text] [Related]
19. Middle-of-the-night administration of sleep medication: a critical review of the effects on next morning driving ability.
Verster JC; van de Loo AJ; Moline ML; Roth T
Curr Drug Saf; 2014; 9(3):205-11. PubMed ID: 24909576
[TBL] [Abstract][Full Text] [Related]
20. Insomnia symptoms among old people in nursing homes.
Skottheim A; Lövheim H; Isaksson U; Sandman PO; Gustafsson M
Int Psychogeriatr; 2018 Jan; 30(1):77-85. PubMed ID: 28927479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
